ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

APPROVED_FOR_MARKETING

Conditions studied: Mesothelioma

In brief

This study is to evaluate the effects (good and bad) of ALIMTA and Cisplatin or ALIMTA alone on you and your malignant pleural mesothelioma as well as make ALIMTA available to patients who qualify for treatment.

Key facts

Study ID

NCT00040625

Run by

Eli Lilly and Company

Last updated by the study team

2007-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a proven diagnosis of malignant mesothelioma in patients not candidates for curative surgery
• Prior chemotherapy for your disease is allowed
• Measurable lesion is not required
• Have a adequate performance status
• Sign an informed consent form

You may not qualify if…

• You are excluded from this trial if you have received any investigational agent within 4 week before enrolling in this study
• You are excluded from this trial if you have received radiation within the previous 2 weeks
• You are excluded from this trial if you are a candidates for curative surgery

Where it is running

• For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. — Basking Ridge, New Jersey, United States
• For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician — Porto Alegre, Rio Grande do Sul, Brazil
• For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician — São Paulo, Brazil
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." — Cairo, Egypt
• For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician — Cairo, Egypt
• For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician — Jeddah, Saudi Arabia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.